FR2920154B1 - Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant - Google Patents

Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant

Info

Publication number
FR2920154B1
FR2920154B1 FR0853768A FR0853768A FR2920154B1 FR 2920154 B1 FR2920154 B1 FR 2920154B1 FR 0853768 A FR0853768 A FR 0853768A FR 0853768 A FR0853768 A FR 0853768A FR 2920154 B1 FR2920154 B1 FR 2920154B1
Authority
FR
France
Prior art keywords
dinitropyrazoles
derivatives
preparation
compositions containing
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0853768A
Other languages
English (en)
Other versions
FR2920154A1 (fr
Inventor
Gregoire Herve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eurenco SA
ArianeGroup SAS
Original Assignee
SNPE Materiaux Energetiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0755679A external-priority patent/FR2917409B1/fr
Application filed by SNPE Materiaux Energetiques SA filed Critical SNPE Materiaux Energetiques SA
Priority to FR0853768A priority Critical patent/FR2920154B1/fr
Priority to US12/314,726 priority patent/US8273784B2/en
Publication of FR2920154A1 publication Critical patent/FR2920154A1/fr
Priority to EP09162086A priority patent/EP2130821B1/fr
Priority to AT09162086T priority patent/ATE525358T1/de
Priority to PT09162086T priority patent/PT2130821E/pt
Priority to US13/595,622 priority patent/US8440839B2/en
Publication of FR2920154B1 publication Critical patent/FR2920154B1/fr
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C06—EXPLOSIVES; MATCHES
    • C06B—EXPLOSIVES OR THERMIC COMPOSITIONS; MANUFACTURE THEREOF; USE OF SINGLE SUBSTANCES AS EXPLOSIVES
    • C06B25/00—Compositions containing a nitrated organic compound
    • C06B25/34—Compositions containing a nitrated organic compound the compound being a nitrated acyclic, alicyclic or heterocyclic amine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/46—Oxygen atom in position 3 or 5 and nitrogen atom in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0853768A 2007-06-12 2008-06-06 Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant Active FR2920154B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0853768A FR2920154B1 (fr) 2007-06-12 2008-06-06 Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant
US12/314,726 US8273784B2 (en) 2007-06-12 2008-12-16 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them
PT09162086T PT2130821E (pt) 2008-06-06 2009-06-05 Derivados do 3,4,5-trinitropirazole, sua preparação composições energéticas que os contêm
AT09162086T ATE525358T1 (de) 2008-06-06 2009-06-05 Derivate von 3,4,5-trinitropyrazol, ihre herstellung und die energetischen zusammensetzungen, die sie enthalten
EP09162086A EP2130821B1 (fr) 2008-06-06 2009-06-05 Dérivés du 3,4,5-trinitropyrazole, leur préparation et les compositions énergétiques les renfermant
US13/595,622 US8440839B2 (en) 2007-06-12 2012-08-27 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755679A FR2917409B1 (fr) 2007-06-12 2007-06-12 Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant.
FR0853768A FR2920154B1 (fr) 2007-06-12 2008-06-06 Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant

Publications (2)

Publication Number Publication Date
FR2920154A1 FR2920154A1 (fr) 2009-02-27
FR2920154B1 true FR2920154B1 (fr) 2016-07-01

Family

ID=44741745

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0853768A Active FR2920154B1 (fr) 2007-06-12 2008-06-06 Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant

Country Status (1)

Country Link
FR (1) FR2920154B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3102477B1 (fr) * 2019-10-23 2021-11-12 Arianegroup Sas Sels d’acides aminés énergétiques à haute balance en oxygène
CN114874154B (zh) * 2022-06-16 2024-06-11 北京理工大学 3，3′-双取代-5，5′-双(1，2，4-噁二唑)类化合物及其制备方法
CN115043778B (zh) * 2022-06-27 2024-02-13 中国工程物理研究院化工材料研究所 烷基取代的4-氨基-3,5-二硝基吡唑类低熔点化合物及其制备方法
CN115340506A (zh) * 2022-08-10 2022-11-15 北京理工大学 一种4-氨基-3-硝氨基噁二唑铜含能化合物及其制备方法

Also Published As

Publication number Publication date
FR2920154A1 (fr) 2009-02-27

Similar Documents

Publication Publication Date Title
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
BRPI0809346A2 (pt) Compostos derivados substituídos de imidazopiridina e composição farmacêutica contendo os mesmos
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0915897A2 (pt) compostos derivados triazóis, composições farmacêuticas e combinações dos mesmos e seus usos
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI1013642A2 (pt) derivado de triazina e composição farmacêutica compreendendo o mesmo
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
FR2933700B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2917409B1 (fr) Derives de dinitropyrazoles, leur preparation et les compositions energetiques les renfermant.
ZA200905671B (en) Heterocyclic compounds, compositions comprising them and methods of their use
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
MA29725B1 (fr) Nouveaux derives tricycliques, leur procede de prepapation et les compositions pharmaceutiques qui les contiennent
IL206060A0 (en) Conjugates of anti-rg-1 antibodies, compositions comprising the same and uses thereof
BRPI0815373A2 (pt) Derivados de ciclo-hexeno e o uso dos mesmos como fragrâncias
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
BRPI0816992A2 (pt) Derivado heterocíclico tricícloco, e, composição farmacêutica
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
FR2903406B1 (fr) Derives de pyrazolylbenzimidazole,compositions les contenant et utilisation
FR2917413B1 (fr) Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
FI20075086A0 (fi) Aromikoostumus
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant

Legal Events

Date Code Title Description
CL Concession to grant licences
TQ Partial transmission of property
CA Change of address

Effective date: 20130213

CD Change of name or company name

Owner name: EURENCO, FR

Effective date: 20130213

Owner name: HERAKLES, FR

Effective date: 20130213

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

CD Change of name or company name

Owner name: ARIANEGROUP SAS, FR

Effective date: 20180620

Owner name: EURENCO, FR

Effective date: 20180620

TQ Partial transmission of property

Owner name: ARIANEGROUP SAS, FR

Effective date: 20180621

Owner name: EURENCO, FR

Effective date: 20180621

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16